Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors
Authors:
Open Access
Abstract
BACKGROUND Mature teratoma is often found in resected retroperitoneal residual tumor masses (RRTM) after chemotherapy for disseminated nonseminomatous testicular germ cell tumors (NSTGCT). The aim of this report is to describe the clinical course of patients after resection of residual teratoma, with particular emphasis on relapse with either growing mature teratoma or secondary non‐germ cell malignancy. METHODS During the period 1979‐1995, 113 patients underwent a laparotomy for resection of RRTM after chemotherapy for NSTGCT. Only patients with mature teratoma in the RRTM were included in the current study, and data on the patients who experienced relapse were studied in detail. RESULTS Mature teratoma was found in 51 patients (45.1%) with RRTM resected after chemotherapy. Nine of these 51 patients (17.6%) relapsed; the relapses resulted from growing mature teratoma in 5 patients (9.8%), secondary non‐germ cell malignancy in 3 patients (5.9%), and recurrent germ cell malignancy in 1 patient (2.0%). The primary treatment for all relapsing patients was surgical excision. All five patients with growing mature teratoma are alive without evidence of disease, as is the patient with recurrent germ cell malignancy. One of the three patients with non‐germ cell malignancy died of disease, and the remaining two are alive with disease. CONCLUSIONS Long term follow‐up after resection of postchemotherapy residual teratoma is indicated because a proportion of patients develop growing mature teratoma or a secondary non‐germ cell malignancy. The treatment for these recurrences should be complete surgical excision. Cancer 1998;82:1343‐51. © 1998 American Cancer Society.Keywords
This publication has 62 references indexed in Scilit:
- Growing Teratoma SyndromeUrologia Internationalis, 1995
- Para‐aortic Lymphadenectomy after Chemotherapy for Metastatic Non‐seminomatous Germ Cell Tumours: Prognostic Value and Therapeutic BenefitBritish Journal of Urology, 1993
- Long-term follow-up of non-seminomatous testicular cancer patients with mature teratoma or carcinoma at postchemotherapy surgeryEuropean Journal of Cancer and Clinical Oncology, 1991
- Cytoreductive surgery in disseminated non-seminomatous germ cell tumours of testisBritish Journal of Surgery, 1991
- Successful treatment of patients in whom germ cell tumour masses enlarged on chemotherapy while their serum tumour markers decreasedEuropean Journal of Cancer and Clinical Oncology, 1989
- Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin‐vinblastine‐bleomycin chemotherapyJournal of Surgical Oncology, 1988
- Non-seminomatous germ cell testicular tumours: Residual masses after chemotherapyBritish Journal of Surgery, 1985
- Significance of the ‘maturation’ of metastases from germ cell tumours after intensive chemotherapyHistopathology, 1984
- The Role of Maintenance Therapy in Disseminated Testicular CancerNew England Journal of Medicine, 1981
- BENIGN TRANSFORMATION OF TESTICULAR CARCINOMA BY CHEMOTHERAPYThe Lancet, 1975